You are here

  • Home
  • Archive
  • Volume 21, Issue 1
  • Dextromethorphan and quinidine are suitable for off-label short-term treatment of agitation in people with Alzheimer's disease following first-line non-drug approaches

Article Text

Article menu
Download PDFPDF
Therapeutics/Prevention
Randomised controlled trial
Dextromethorphan and quinidine are suitable for off-label short-term treatment of agitation in people with Alzheimer's disease following first-line non-drug approaches

https://doi.org/10.1136/ebmed-2015-110324

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Twitter Follow Anne Corbett at @DrAnneCorbett

    • Funding NIHR, Maudsley Biomedical Research Unit for Dementia.

    • Competing interests None declared.

    • Provenance and peer review Commissioned; internally peer reviewed.